Skip to main content
Log in

Structures of the Mouse Central Nervous System Contain Different Quantities of Proteasome Gene Transcripts

  • GENOMICS. TRANSCRIPTOMICS
  • Published:
Molecular Biology Aims and scope Submit manuscript

Abstract

Proteasomes are multisubunit complexes that degrade most intracellular proteins. Three of the 14 subunits of the 20S proteasome, specifically β1, β2, and β5, demonstrate catalytic activity and hydrolyze peptide bonds after acidic, basic, and hydrophobic amino acids, respectively. Within proteasome, the constitutive catalytic subunits β1, β2, and β5 can be substituted by the immune β1i, β2i, and β5i subunits, respectively. However, proteasomes do not always contain all the immune subunits at once; some proteasomes contain both immune and constitutive catalytic subunits simultaneously. Incorporation of immune subunits modifies the pattern of peptides produced by proteasomes. This is essential for antigen presentation and cellular response to stress as well as for a number of intracellular signaling pathways. We have developed a quantitative PCR-based system for the determination of the absolute levels of murine constitutive and immune proteasome subunits gene expression. Using the obtained system, we have estimated the expression levels of genes encoding proteasome subunits in the mouse central nervous system (CNS) tissues. We have shown that the quantity of transcripts of proteasome catalytic subunits in different CNS structures differed significantly. These data allow us to assume that the studied brain regions can be divided into two groups, with relatively “high” (cerebral cortex and spinal cord) and “low” (hippocampus and cerebellum) levels of proteasome subunit genes expression. Moreover, it was possible to distinguish structures with similar and significantly different gene expression profiles of proteasome catalytic subunits. Thus, the gene expression profiles in the cortex, spinal cord, and cerebellum were similar, but different from the expression profile in the hippocampus. Based on the obtained data, we suggest that there are differences in the proteasome pool, as well as in the functional load on the ubiquitin–proteasome system in different parts of the CNS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

Notes

  1. Abbreviations: CNS, central nervous system; UPS, ubiquitin-proteasome system.

REFERENCES

  1. Groll M., Ditzel L., Löwe J., Stock D., Bochtler M., Bartunik H.D., Huber R. 1997. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature. 386 (6624), 463–471.

    Article  CAS  Google Scholar 

  2. Heinemeyer W., Fischer M., Krimmer T., Stachon U., Wolf D.H. 1997. The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing. J. Biol. Chem. 272, 25200–25209.

    Article  CAS  Google Scholar 

  3. Rousseau A., Bertolotti A. 2018. Regulation of proteasome assembly and activity in health and disease. Nat. Rev. Mol. Cell Biol. 19 (11), 697‒712.

    Article  CAS  Google Scholar 

  4. Dantuma N.P., Bott L.C. 2014. The ubiquitin–proteasome system in neurodegenerative diseases: Precipitating factor, yet part of the solution. Front. Mol. Neurosci. 7, 70.

    Article  Google Scholar 

  5. Morozov A.V., Karpov V.L. 2019. Proteasomes and several aspects of their heterogeneity relevant to cancer. Front. Oncol. 9, 761.

    Article  Google Scholar 

  6. Kors S., Geijtenbeek K., Reits E., Schipper-Krom S. 2019. Regulation of proteasome activity by (post-)transcriptional mechanisms. Front. Mol. Biosci. 6, 48.

    Article  CAS  Google Scholar 

  7. Pickering A.M., Koop A.L., Teoh C.Y., Ermak G., Grune T., Davies K.J. 2010. The immunoproteasome, the 20S proteasome and the PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem. J. 432, 585–594.

    Article  CAS  Google Scholar 

  8. Ferrington D.A., Gregerson D.S. 2012. Immunoproteasomes: Structure, function, and antigen presentation. Prog. Mol. Biol. Transl. Sci. 109, 75–112.

    Article  CAS  Google Scholar 

  9. Guillaume B., Chapiro J., Stroobant V., Colau D., Van Holle B., Parvizi G., Bousquet-Dubouch M.-P., Théate I., Parmentier N., Van den Eynde B. J. 2010. Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules. Proc. Natl. Acad. Sci. U. S. A. 107, 18599–18604.

    Article  CAS  Google Scholar 

  10. Morozov A.V., Karpov V.L. 2018. Biological consequences of structural and functional proteasome diversity. Heliyon. 4 (10), e00894.

    Article  Google Scholar 

  11. Morozov A.V., Burov B.A., Astakhova T.M., Spasskaya D.S., Margulis B.A., Karpov V.L. 2019. Dynamics of the functional activity and expression of proteasome subunits during cellular adaptation to heat shock. Mol. Biol. (Moscow). 53 (4), 571‒579.

    Article  CAS  Google Scholar 

  12. Kunjappu M.J., Hochstrasser M. 2014. Assembly of the 20S proteasome. Biochim. Biophys. Acta. 1843 (1), 2‒12.

  13. Cembrowski M.S., Wang L., Sugino K., Shields B.C., Spruston N. 2016. Hipposeq: A comprehensive RNA-seq database of gene expression in hippocampal principal neurons. eLife. 5, e14997.

    Article  Google Scholar 

  14. Funikov S.Y., Rezvykh A.P., Mazin P.V., Morozov A.V., Maltsev A.V., Chicheva M.M., Vikhareva E.A., Evgen’ev M.B., Ustyugov A.A. 2018. FUS(1‒359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy. Neurogenetics. 19 (3), 189‒204.

    Article  CAS  Google Scholar 

  15. Liu Q., Huang S., Yin P., Yang S., Zhang J., Jing L., Cheng S., Tang B., Li X-J., Pan Y., Li S. 2020. Cerebellum-enriched protein INPP5A contributes to selective neuropathology in mouse model of spinocerebellar ataxias type 17. Nat. Commun. 11 (1), 1101.

    Article  CAS  Google Scholar 

  16. Corriveau R.A., Huh G.S., Shatz C.J. 1998. Regulation of class I MHC gene expression in the developing and mature CNS by neural activity. Neuron. 21 (3), 505‒520.

    Article  CAS  Google Scholar 

  17. McAllister A.K. 2014. Major histocompatibility complex I in brain development and schizophrenia. Biol. Psychiatry. 75 (4), 262–268.

    Article  CAS  Google Scholar 

  18. Ramachandran K.V., Margolis S.S. 2017. A mammalian nervous-system-specific plasma membrane proteasome complex that modulates neuronal function. Nat. Struct. Mol. Biol. 24 (4), 419–430.

    Article  CAS  Google Scholar 

  19. Ramachandran K.V., Fu J.M., Schaffer T.B., Na C.H., Delannoy M., Margolis S.S. 2018. Activity-dependent degradation of the nascentome by the neuronal membrane proteasome. Mol. Cell. 71 (1), 169–177.e6.

    Article  CAS  Google Scholar 

  20. Orre M., Kamphuis W., Dooves S., Kooijman L., Chan E.T., Kirk C.J., Dimayuga Smith V., Koot S., Mamber C., Jansen A.H., Ovaa H., Hol E.M. 2013. Reactive glia show increased immunoproteasome activity in Alzheimer’s disease. Brain. 136 (5), 1415‒1431.

    Article  Google Scholar 

  21. Frentzel S., Kuhn-Hartmann I., Gernold M., Gött P., Seelig A., Kloetzel P.M. 1993. The major-histocompatibility-complex-encoded beta-type proteasome subunits LMP2 and LMP7. Evidence that LMP2 and LMP7 are synthesized as proproteins and that cellular levels of both mRNA and LMP-containing 20S proteasomes are differentially regulated. Eur. J. Biochem. 216 (1), 119‒126.

    Article  CAS  Google Scholar 

Download references

Funding

This study was supported by the Russian Science Foundation, grant no. 18-74-10095. Animal housing was supported by the Program for Support of Bioresource Collections of the Institute of Physiologically Active Substances, Russian Academy of Sciences, Federal Agency of Scientific Organizations, project no. 0090-2017-0016.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. V. Morozov.

Ethics declarations

Conflict of interest. The authors declare no conflict of interest.

Statement on the welfare of animals. The experiments were performed in accordance with the international, national, and/or institutional guidelines for the care and use of animals, and with the Order of the Ministry of Health Care of the Russian Federation no. 199n, April 1, 2016 “On approval of the rules of good laboratory practice.”

Additional information

Translated by M. Stepanichev

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Funikov, S.Y., Spasskaya, D.S., Burov, A.V. et al. Structures of the Mouse Central Nervous System Contain Different Quantities of Proteasome Gene Transcripts. Mol Biol 55, 47–55 (2021). https://doi.org/10.1134/S0026893320060047

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0026893320060047

Keywords:

Navigation